Physician profile
Viktor Ballada
NPI 1972543460
$1,203.99
in general payments reported to CMS, 2019-2025
15 companies · $433 in 2025
The $433 reported for 2025 was more than what a typical Undersea and Hyperbaric Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $210).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.83 · 2020: $58.59 · 2021: $31.66 · 2022: $112 · 2023: $316 · 2024: $174 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $282.72 | 2019-2025 | Collagenase Santyl, Regranex, Oasis |
| Mimedx Group, INC. | $247.49 | 2025 | |
| Organogenesis INC. | $138.46 | 2019-2023 | Puraply |
| Molnlycke Health Care US, LLC | $123.46 | 2023 | Tubigrip, Exufiber Ag+, Mepilex Lite |
| Koya Medical, INC. | $120.98 | 2023 | Dayspring |
| Convatec INC. | $75.88 | 2021-2025 | |
| Solventum Corporation | $49.31 | 2024-2025 | V.A.C. Veraflo, Activ.A.C. |
| Abbvie INC. | $27.93 | 2023 | Dalvance |
| Kerecis Limited | $27.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Hydrofera LLC | $25.86 | 2022 | |
| Integra Lifesciences Corporation | $21.22 | 2024 | Tcc-Ez |
| Kci USA, INC. | $20.40 | 2022 | |
| Ets Wound Care LLC | $15.75 | 2025 | Mirragen Advanced Wound Matrix |
| Hartmann USA, INC. | $13.65 | 2024 | Zetuvit Plus 10x10 P10 |
| Sanara Medtech INC. | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viktor Ballada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.